NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,999,929 | -11.7% | 67,795 | -2.9% | 0.11% | -13.3% |
| Q2 2023 | $3,398,366 | +39.2% | 69,839 | +58.9% | 0.13% | +25.5% |
| Q1 2023 | $2,440,826 | +149.9% | 43,963 | +80.8% | 0.10% | +72.9% |
| Q4 2022 | $976,573 | +4.4% | 24,311 | +14.0% | 0.06% | +1.7% |
| Q3 2022 | $935,000 | -57.5% | 21,333 | -65.6% | 0.06% | -28.4% |
| Q2 2022 | $2,201,000 | -38.5% | 62,091 | -29.5% | 0.08% | -42.1% |
| Q1 2022 | $3,581,000 | +387.9% | 88,039 | +1235.9% | 0.14% | +233.3% |
| Q3 2021 | $734,000 | -76.4% | 6,590 | -75.9% | 0.04% | -79.0% |
| Q2 2021 | $3,109,000 | +605.0% | 27,387 | +531.0% | 0.20% | +809.1% |
| Q1 2021 | $441,000 | -17.3% | 4,340 | -19.0% | 0.02% | -4.3% |
| Q4 2020 | $533,000 | +23.7% | 5,360 | -38.0% | 0.02% | +4.5% |
| Q2 2020 | $431,000 | +75.9% | 8,651 | +5.2% | 0.02% | +22.2% |
| Q1 2020 | $245,000 | -68.5% | 8,220 | -64.4% | 0.02% | -47.1% |
| Q4 2019 | $777,000 | – | 23,060 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |